Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

OPKO Health Inc (NASDAQ:OPK)

6.96
Delayed Data
As of Oct 20
 +0.21 / +3.11%
Today’s Change
5.85
Today|||52-Week Range
12.15
-25.16%
Year-to-Date

Today’s Trading

Previous close6.75
Today’s open6.74
Day’s range6.72 - 6.99
Volume3,531,296
Average volume (3 months)4,515,738
Market cap$3.9B
Dividend yield--
Data as of 3:59pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)+16.67%
Earnings growth (this year)-283.33%
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)+148.44%
P/E ratioNM
Price/Sales4.19
Price/Book1.86

Competitors

 Today’s
change
Today’s
% change
PTLAPortola Pharmaceutic...+0.18+0.36%
PBYIPuma Biotechnology I...+3.05+2.51%
CLVSClovis Oncology Inc+0.73+0.95%
MNKMallinckrodt Plc-0.40-1.22%
Data as of 4:02pm ET, 10/20/2017

Financials

Next reporting dateNovember 13, 2017
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$1.2B
Annual profit (last year)-$25.1M
Net profit margin-2.05%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Phillip Frost
Chief Financial Officer &
Senior Vice President
Adam E. Logal
Corporate headquarters
Miami, Florida

Forecasts